Beallucanbe

[Beallucanbe @Beallucanbe3]

@CraigBrockie @The_Life_Pad @grok are there any trials accepting enrollment

[Beallucanbe @Beallucanbe3]

@BlueDot_Techs @ericjackson I appreciate your insights….How does this look in comparison to $BTQ? It seems like that has similar characteristics?

[Beallucanbe @Beallucanbe3]

@TestoConsultant Free

[Beallucanbe @Beallucanbe3]

@theficouple Attend

[Beallucanbe @Beallucanbe3]

@BPharmCatalyst $TNXP

PDFUA date of August 15

[Beallucanbe @Beallucanbe3]

@BPharmCatalyst $TNXP

The U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 15, 2025. If approved, Tonmya would be the first new drug approved for fibromyalgia in over 15 years.

[Beallucanbe @Beallucanbe3]

@BPharmCatalyst $TNXP

This delivery method allows for rapid transmucosal absorption and limits the formation of norcyclobenzaprine, a long half-life metabolite.

[Beallucanbe @Beallucanbe3]

@BPharmCatalyst $TNXP

In prior data, Tonmya demonstrated statistically significant improvement in reducing fibromyalgia-related pain and was generally well tolerated. The U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 15

[Beallucanbe @Beallucanbe3]

@BPharmCatalyst $TNXP

Common symptoms include widespread pain, fatigue, nonrestorative sleep, and cognitive disturbances, with current treatment options often failing to meet patient and physician expectations.

[Beallucanbe @Beallucanbe3]

@BPharmCatalyst $TNXP

The pivotal Phase 3 RELIEF and RESILIENT trials evaluate the efficacy and safety of once-nightly TNX-102 SL 5.6 mg in patients with fibromyalgia, a condition that affects an estimated 6 to 12 million adults in the U.S., predominantly women.

[Beallucanbe @Beallucanbe3]

@BPharmCatalyst $TNXP

Its lead product candidate is TNX-102 SL, branded as Tonmya, a patented sublingual formulation of cyclobenzaprine hydrochloride designed to bypass first-pass hepatic metabolism.

[Beallucanbe @Beallucanbe3]

@theficouple Analyze

[Beallucanbe @Beallucanbe3]

@alc2022 have you looked into $btq as a quantum security play….seems to have little to no competition in the field and a long runway.

[Beallucanbe @Beallucanbe3]

@SmallCapBob2 I appreciate you putting me on to this opportunity!!!

I got in on Novavax back in 2020 and had similar reward but played it poorly and got to aggressive. I think I have a better understanding now to take advantage of this gift 🎁

[Beallucanbe @Beallucanbe3]

@traders_kings What about $asml and $iwm

[Beallucanbe @Beallucanbe3]

@traders_kings @trynaobserve16 How about $hims and $tsla?

[Beallucanbe @Beallucanbe3]

@traders_kings Should we double down on $iwm after a consolidation day yesterday?

[Beallucanbe @Beallucanbe3]

@traders_kings Glad I saw this one in real time-in with you for 10 at $250 with May expiry.

[Beallucanbe @Beallucanbe3]

@traders_kings what do you think of $hims